Back to search

Article

Cerebrolysin, Hemorrhagic Transformation, and Anticoagulation Timing after Reperfusion Therapy in Stroke: Secondary Analysis of the CEREHETIS Trial

2024-10-18

Abstract excerpt

<title>Abstract</title> <p> Background Evidence supports Cerebrolysin’s efficacy in reducing hemorrhagic transformation (HT), but its impact on the timing of resuming anticoagulation therapy in stroke patients remains unclear. Methods A <italic>post hoc</italic> survival analysis of the CEREHETIS trial (ISRCTN87656744) was conducted. Patients with middle cerebral artery infarction ( <italic>n</italic>  = 2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1a023e7c-0dfc-582a-ab29-84a349fdf8e3
DOI
10.21203/rs.3.rs-5101232/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cerebrolysin, Hemorrhagic Transformation, and Anticoagulation Timing after Reperfusion Therapy in Stroke: Secondary Analysis of the CEREHETIS TrialDOI 10.21203/rs.3.rs-5101232/v1
Select a neighboring publication to make it the new centre.